J&J Resolves Most Lawsuits Over Anti-Psychotic Drug, Reports $800M in Legal Expenses Over Issue
Carrier Management - Nov 01, 2021
J&J Resolves Most Lawsuits Over Anti-Psychotic Drug, Reports $800M in Legal Expenses Over Issue Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed ......
Recommended Articles
Posted: Feb 25, 2026
Majority of Companies Worldwide See AI Benefits; Coverage Vague: Survey A recent survey of more than...
Posted: Feb 25, 2026
Majority of Companies Worldwide See AI Benefits Despite Ongoing Challenges: Survey A recent survey o...
Posted: Feb 25, 2026
Camp Mystic Parents Sue Texas, Allege Evacuation Plan Requirement Not Enforced Texas health official...